Cargando…
Recognizing early signs in the translational phase is essential for drug development in cardiovascular medicine
Autores principales: | Papp, Zoltán, Pollesello, Piero, Borbély, Attila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375176/ https://www.ncbi.nlm.nih.gov/pubmed/37165705 http://dx.doi.org/10.1002/ehf2.14402 |
Ejemplares similares
-
Inotropes and Inodilators for Acute Heart Failure: Sarcomere Active Drugs in Focus
por: Nagy, László, et al.
Publicado: (2014) -
Levosimendan‐induced venodilation is mediated by opening of potassium channels
por: Burkhoff, Daniel, et al.
Publicado: (2021) -
The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
por: Levijoki, Jouko, et al.
Publicado: (2022) -
Introducing the Cardiovascular, metabolic and lipoprotein translation section of journal of translational medicine
por: Mehta, Nehal N
Publicado: (2012) -
Editorial: The launch phase of Bioengineering & Translational Medicine
por: Mitragotri, Samir
Publicado: (2019)